Ashish Ranjan to Adjuvants, Immunologic
This is a "connection" page, showing publications Ashish Ranjan has written about Adjuvants, Immunologic.
Connection Strength
0.655
-
Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy. Pharmacol Ther. 2020 03; 207:107456.
Score: 0.655